AbbVie Sues Generic Drugmaker Sun Over Zemplar Patent

[Anonymous]

AbbVie sued Indian generic drugmaker Sun Pharmaceutical Industries Ltd. for infringing a patent for Zemplar, used to treat kidney patients.

The case is AbbVie v. Sun, 13-cv-00138, U.S. District Court, District of Delaware (Wilmington).

 

[Anonymous]

AbbVie sued Indian generic drugmaker Sun Pharmaceutical Industries Ltd. for infringing a patent for Zemplar, used to treat kidney patients.

The case is AbbVie v. Sun, 13-cv-00138, U.S. District Court, District of Delaware (Wilmington).

Good luck with that one. The governments in the BRICs and Africa have been allowing companies to steal IP from big pharma for years and years. They say it's "necessary" for the health of their people.

 

[Anonymous]

Gordon will provide you with the "scoop".